GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ADMA Biologics Inc (NAS:ADMA) » Definitions » E10

ADMA (ADMA Biologics) E10 : $-1.08 (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is ADMA Biologics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

ADMA Biologics's adjusted earnings per share data for the three months ended in Mar. 2025 was $0.110. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.08 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average E10 Growth Rate was 13.70% per year. During the past 5 years, the average E10 Growth Rate was 8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of ADMA Biologics was 13.70% per year. The lowest was 3.00% per year. And the median was 6.90% per year.

As of today (2025-07-07), ADMA Biologics's current stock price is $17.88. ADMA Biologics's E10 for the quarter that ended in Mar. 2025 was $-1.08. ADMA Biologics's Shiller PE Ratio of today is .


ADMA Biologics E10 Historical Data

The historical data trend for ADMA Biologics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ADMA Biologics E10 Chart

ADMA Biologics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.75 -1.74 -1.67 -1.41 -1.12

ADMA Biologics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.34 -1.28 -1.22 -1.12 -1.08

Competitive Comparison of ADMA Biologics's E10

For the Biotechnology subindustry, ADMA Biologics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ADMA Biologics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ADMA Biologics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ADMA Biologics's Shiller PE Ratio falls into.


;
;

ADMA Biologics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ADMA Biologics's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.11/134.9266*134.9266
=0.110

Current CPI (Mar. 2025) = 134.9266.

ADMA Biologics Quarterly Data

per share eps CPI Adj_EPS
201506 -0.440 100.684 -0.590
201509 -0.480 100.392 -0.645
201512 -0.450 99.792 -0.608
201603 -0.430 100.470 -0.577
201606 -0.500 101.688 -0.663
201609 -0.340 101.861 -0.450
201612 -0.350 101.863 -0.464
201703 -0.510 102.862 -0.669
201706 -0.550 103.349 -0.718
201709 -0.590 104.136 -0.764
201712 -0.286 104.011 -0.371
201803 -0.390 105.290 -0.500
201806 -0.350 106.317 -0.444
201809 -0.330 106.507 -0.418
201812 -0.390 105.998 -0.496
201903 -0.280 107.251 -0.352
201906 -0.250 108.070 -0.312
201909 -0.190 108.329 -0.237
201912 -0.180 108.420 -0.224
202003 -0.260 108.902 -0.322
202006 -0.230 108.767 -0.285
202009 -0.190 109.815 -0.233
202012 -0.200 109.897 -0.246
202103 -0.160 111.754 -0.193
202106 -0.150 114.631 -0.177
202109 -0.130 115.734 -0.152
202112 -0.090 117.630 -0.103
202203 -0.130 121.301 -0.145
202206 -0.070 125.017 -0.076
202209 -0.080 125.227 -0.086
202212 -0.060 125.222 -0.065
202303 -0.030 127.348 -0.032
202306 -0.030 128.729 -0.031
202309 0.010 129.860 0.010
202312 -0.080 129.419 -0.083
202403 0.080 131.776 0.082
202406 0.130 132.554 0.132
202409 0.150 133.029 0.152
202412 0.460 133.157 0.466
202503 0.110 134.927 0.110

Add all the adjusted EPS together and divide 10 will get our e10.


ADMA Biologics  (NAS:ADMA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


ADMA Biologics E10 Related Terms

Thank you for viewing the detailed overview of ADMA Biologics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


ADMA Biologics Business Description

Traded in Other Exchanges
N/A
Address
465 State Route 17, Ramsey, NJ, USA, 07446
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Executives
Lawrence P. Guiheen director 65 COMMERCE WAY, HACKENSACK NJ 07601
Adam S Grossman director, officer: President and CEO 65 COMMERCE WAY, HACKENSACK NJ 07601
Jerrold B Grossman director 65 COMMERCE WAY, HACKENSACK NJ 07601
Young Kwon director C/O MOMENTA PHARMACEUTICALS INC., 675 WEST KENDALL STREET, CAMBRIDGE MA 02142
Steve Elms director 888 SEVENTH AVE, 29TH FL, NEW YORK NY 10106
Alison Cecily Finger director C/O BLUEBIRD BIO, INC., 60 BINNEY STREET, CAMBRIDGE MA 02142
Bryant Fong director 2170 VALLEJO STREET #101, SAN FRANCISCO CA 94123
Brian Lenz officer: EVP, CFO 65 COMMERCE WAY, HACKENSACK NJ 07601
Martha J Demski director 7770 REGENTS ROAD SUITE 113-505, SAN DIEGO CA 92122
Perceptive Life Sciences Master Fund Ltd 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
James Mond officer: CSO/CMO 65 COMMERCE WAY, HACKENSACK NJ 07601
Biotest Divestiture Trust 10 percent owner C/O ERIC ROSENBACH, TRUSTEE, 402 NORFOLK STREET, CAMBRIDGE MA 02139
Perceptive Advisors Llc 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Joseph Edelman 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Eric I Richman director C/O REV CAPITAL II, LLC, 9740 SORREL AVE, POTOMAC MD 20854